Giovanni Targher mainly investigates Internal medicine, Endocrinology, Diabetes mellitus, Nonalcoholic fatty liver disease and Type 2 diabetes. Internal medicine is often connected to Gastroenterology in his work. In his research on the topic of Endocrinology, Reference range, Alcohol abuse, Risk of mortality and Cancer is strongly related with Epidemiology.
His study in Diabetes mellitus is interdisciplinary in nature, drawing from both Obesity, Risk factor, Cohort and Hazard ratio. Giovanni Targher interconnects Meta-analysis and Liver biopsy in the investigation of issues within Nonalcoholic fatty liver disease. His work deals with themes such as Aerobic exercise and Hepatology, which intersect with Type 2 diabetes.
His main research concerns Internal medicine, Endocrinology, Diabetes mellitus, Gastroenterology and Type 2 diabetes. His study looks at the intersection of Internal medicine and topics like Cardiology with Surgery. In most of his Endocrinology studies, his work intersects topics such as Risk factor.
His Diabetes mellitus study incorporates themes from Blood pressure and Hazard ratio. The concepts of his Gastroenterology study are interwoven with issues in Fibrosis and Steatohepatitis. Giovanni Targher has researched Nonalcoholic fatty liver disease in several fields, including Cirrhosis and Liver biopsy.
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Fatty liver, Nonalcoholic fatty liver disease and Disease. Giovanni Targher has included themes like Diabetes mellitus, Type 2 diabetes and Cardiology in his Internal medicine study. Type 2 diabetes is the subject of his research, which falls under Endocrinology.
The study incorporates disciplines such as Body mass index, Obesity, Metabolic syndrome, Biopsy and Receiver operating characteristic in addition to Fatty liver. His Nonalcoholic fatty liver disease research includes themes of Pathogenesis, Bioinformatics, Confidence interval, Liver disease and Insulin resistance. His Disease course of study focuses on Intensive care medicine and Multisystem disease.
Giovanni Targher spends much of his time researching Internal medicine, Fatty liver, Disease, Gastroenterology and Diabetes mellitus. As part of the same scientific family, Giovanni Targher usually focuses on Internal medicine, concentrating on Type 2 diabetes and intersecting with Transient elastography. Giovanni Targher studied Fatty liver and Bone mineral that intersect with Bone remodeling.
His Gastroenterology research incorporates elements of Fibrosis, Genotype and Insulin resistance. His research integrates issues of Severity of illness and Risk factor in his study of Diabetes mellitus. His Nonalcoholic fatty liver disease study combines topics from a wide range of disciplines, such as Metabolic syndrome and Bioinformatics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
E Bonora;G Targher;M Alberiche;R C Bonadonna.
Diabetes Care (2000)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Mohammed Eslam;Philip N. Newsome;Shiv K. Sarin;Quentin M. Anstee.
Journal of Hepatology (2020)
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Stefano Ballestri;Stefano Zona;Giovanni Targher;Dante Romagnoli.
Journal of Gastroenterology and Hepatology (2016)
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Amedeo Lonardo;Fabio Nascimbeni;Alessandro Mantovani;Giovanni Targher.
Journal of Hepatology (2018)
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Amedeo Lonardo;Stefano Bellentani;Curtis K. Argo;Stefano Ballestri.
Digestive and Liver Disease (2015)
Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
Alessandro Mantovani;Christopher D Byrne;Christopher D Byrne;Enzo Bonora;Giovanni Targher.
Diabetes Care (2018)
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies
Gong Feng;Kenneth I. Zheng;Qin-Qin Yan;Rafael S. Rios.
Journal of clinical and translational hepatology (2020)
Serum 25-hydroxyvitamin D3 Concentrations and Carotid Artery Intima-Media Thickness Among Type 2 Diabetic Patients
Giovanni Targher;Lorenzo Bertolini;Roberto Padovani;Luciano Zenari.
Clinical Endocrinology (2006)
Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial).
Elisabetta Bacchi;Carlo Negri;Giovanni Targher;Niccolò Faccioli.
Nonalcoholic Fatty Liver Disease: A Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications
Giovanni Targher;Christopher D. Byrne;Christopher D. Byrne.
The Journal of Clinical Endocrinology and Metabolism (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: